Fairvalue-Calculator Fairvalue-Calculator
EN DE

Anhui Sunhere Pharmaceutical Excipients Co (300452) Fair Value & Analysis

Healthcare · CN · Market cap 2.8B CNY

Price¥12.00
Fair Value¥14.71
Upside+22.6%
Quality89/100
Evidence: Medium Range ¥9.77 – ¥20.44

Fair value as of: Jun 24, 2026

Analysis

Anhui Sunhere Pharmaceutical Excipients Co (300452) currently trades at ¥12.00, while our model-based Fair Value estimate is ¥14.71 — implying the stock looks roughly 22.6% undervalued today. We read business quality at 89/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. research and development, production, and sale of new pharmaceutical excipients in China. The company provides cellulose, starch, povidone, stearic acid, coating powder, resin, food additive, and other products. It also exports its products. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. was founded in 2001 and is based in Huainan, China.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +1949% Jiangsu Hengrui Pharmaceuticals Co (600276) -46% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -74% Hansoh Pharmaceutical Group (3692) -47% Divi's Laboratories Limited (DIVISLAB) -70%

Frequently asked questions

Is Anhui Sunhere Pharmaceutical Excipients Co (300452) undervalued?
As of Jun 24, 2026, our model estimates a fair value of ¥14.71 versus a price of ¥12.00 — about +23% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 300452?
Our 21-model fair value for Anhui Sunhere Pharmaceutical Excipients Co is ¥14.71 (as of Jun 24, 2026), built from audited fundamentals. The current price is ¥12.00.
What is the quality score of 300452?
Anhui Sunhere Pharmaceutical Excipients Co has a Quality Score of 89/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.